Código QR

Progression analysis versus traditional methods to quantify slowing of disease progression in Alzheimer’s disease

Abstract Background The clinical meaningfulness of the effects of recently approved disease-modifying treatments (DMT) in Alzheimer’s disease is under debate. Available evidence is limited to short-term effects on clinical rating scales which may be difficult to interpret and have limited intrinsic...

Descrición completa

Gardado en:
Principais autores: Linus Jönsson, Milana Ivkovic, Alireza Atri, Ron Handels, Anders Gustavsson, Julie Hviid Hahn-Pedersen, Teresa León, Mathias Lilja, Jens Gundgaard, Lars Lau Raket
Formato: Artigo
Idioma:Inglês
Publicado: BMC 2024-02-01
Series:Alzheimer’s Research & Therapy
Assuntos:
Alzheimer’s disease
Disease progression
Statistical model
Acceso en liña:https://doi.org/10.1186/s13195-024-01413-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares